Biotech · Private company · Tucker, GA, US
Expression Therapeutics
Track this companyFree. Adds Expression Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- ADEPT-STAR therapy for high risk neuroblastomaFiscal year 2026 · $1.1MNIH RePORTER 2R44CA281633-02A1 · fetched Nov 12, 2026
- Allogeneic cell and gene therapy for neuroendocrine tumorsFiscal year 2025 · $400KNIH RePORTER 1R43CA291373-01A1 · fetched Nov 12, 2026